According to a recent World Health Organization estimate, the severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) pandemic, which originated in China in 2019, has …

Vaccines comprising innovative adjuvants are rapidly reaching advanced translational
stages, such as the authorized nanotechnology adjuvants in mRNA vaccines against COVID …

Background: Infectious diseases and vaccines can occasionally cause new-onset or flare of
immune-mediated diseases (IMDs). The adjuvanticity of the available SARS-CoV-2 vaccines …

Autoimmune/inflammatory syndrome induced by adjuvants (ASIA) was first introduced in
2011 by Shoenfeld et al. and encompasses a cluster of related immune mediated diseases …

Neuroimmunological diseases and their treatment compromise the immune system, thereby
increasing the risk of infections and serious illness. Consequently, vaccinations to protect …

The severe acute respiratory syndrome coronavirus 2-induced coronavirus disease 2019
(COVID-19) has had a global spread. Vaccines play an essential role in preventing the …

The mRNA-1273 vaccine, popularly called the" Moderna vaccine" is being widely
administered in the United States for the prevention of COVID-19 infection since December …

Neurological and neurodegenerative diseases, particularly those related to aging, are on
the rise, but drug therapies are rarely curative. Functional disorders and the organic …

Background and aims. Patients with Myasthenia gravis (MG) are considered vulnerable as
they may present with respiratory muscle weakness and because they are on …

The discovery and approved treatment with immune checkpoint inhibitors (ICIs) for a variety
of cancers has changed dramatically the morbidity and mortality rates for these patients …